Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mireia Constans"'
Autor:
Raquel Santiago, Jaume Trapé, Rosario Lopez, Albert Altes, Cristina Motllo, J. Carlos Reverter, Mireia Constans, Lidia Jimenez
Publikováno v:
Thrombosis Research
Background Thromboembolic disease is a frequent cause of death during SARS CoV-2 infection. Lupus anticoagulant (LA) appears frequently during the acute phase of infection. It is not clear whether it is merely an epiphenomenon or whether it is relate
Autor:
María Ángeles de Juan Pardo, Alba Vall Vargas, Albert Gallart Fernández-Puebla, Albert Altes Hernandez, Mireia Constans Cots, Anna Arnau
Publikováno v:
Medicina Clínica (English Edition). 154:388-393
To compare the efficacy of a self-monitoring programme vs. the conventional method used before the intervention in maintaining the international normalised ratio (INR) in the therapeutic range in patients receiving oral anticoagulants, as well as com
Autor:
María Ángeles de Juan Pardo, Anna Arnau, Albert Gallart Fernández-Puebla, Mireia Constans Cots, Albert Altes Hernandez, Alba Vall Vargas
Publikováno v:
Medicina Clínica. 154:388-393
Resumen Introduccion y objetivo Evaluar la eficacia de un programa de autocontrol en pacientes con tratamiento anticoagulante oral (TAO) en el mantenimiento del nivel ratio internacional normalizada (INR) en rango terapeutico vs. el metodo tradiciona
Autor:
Pável Olivera, Miren Gabilondo, Mireia Constans, Dolors Tàssies, Esther Plensa, Verónica Pons, Germán Las Heras, Carmen Jiménez, Desirée Campoy, Anna Bustins, Artur Oliver, Cristina Marzo, Tania Canals, Anna Varela, Marc Sorigue, Eva Sánchez, Gabriela Ene, Granada Perea, Laura Vicente, Meritxell López, María Cerdá, Erik Johansson, M. Reyes Aguinaco, Nazly Santos, José Mateo, Joan Carles Reverter, Ángel Moya, Amparo Santamaría
Publikováno v:
Medicina clinica. 151(5)
In recent years, direct oral anticoagulants (DOACs) have become an alternative to vitamin K antagonists (VKA) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) as well as for prevention and tr
Autor:
Mireia Constans, A. Varela, Amparo Santamaría, Tania Canals, Pável E Olivera, N. Vallejos, Francesc Bosch, Erik Johansson, Verónica Pons, Vicente Cortina
Publikováno v:
Thrombosis Research. 151:S117-S118
Autor:
Tania Canals, Cristina Marzo, Pável E Olivera, Laura Vicente, Artur Oliver, Maria Cerda, Anna Bustins, Germán Las Heras, Esther Plensa, Marc Sorigue, Amparo Santamaría, Anna Varela, Desirée Campoy, Granada Perea, Erik Johansson, Eva Sánchez, M. Reyes Aguinaco, Mireia Constans, Carmen Jiménez, Verónica Pons, Meritxell López, Joan Carles Reverter, Gabriela S Ene, Nazly Santos, Angel Moya M.D., Dolors Tàssies, Miren Gabilondo, José Mateo
Publikováno v:
Medicina Clínica. 151:210.e1-210.e13
Resumen Antecedentes y objetivos En los ultimos anos los anticoagulantes orales directos (ACOD) se han convertido en una alternativa a los antagonistas de la vitamina K (AVK) para la prevencion del ictus y embolia sistemica en pacientes con fibrilaci
Autor:
Joan Carles Souto, Jordi Fontcuberta, Mireia Constans, José Mateo, Amparo Santamaría, N. Pujol
Publikováno v:
International Journal of Clinical Practice. 61:212-217
Nowadays, most patients under oral anticoagulant therapy (OAT) require invasive procedures such as colonoscopy (CC) or gastroscopy (GC). The goals of the management of OAT are to minimise the risk of thromboembolism and bleeding. We have performed th
Publikováno v:
Journal of Hematology & Thromboembolic Diseases.
Francesca Reguant1*, Mireia Constans2, Elena Martinez1 , Albert Altes2 and Joan Bosch3 1Department of Anesthesiology, Althaia Xarxa Assistencial Universitaria de Manresa, Barcelona, Spain 2Department of Haematology, Althaia Xarxa Assistencial Univers
Autor:
Tania Canals, Amparo Santamaría, Francesc Bosch, Eugenia Rivero, Granada Perea, Mireia Constans, Crisitina Marzo, Olga Gavin, Verónica Pons, Pável E Olivera, Erik Johansson
Publikováno v:
Blood. 128:1442-1442
Introduction The use of direct oral anticoagulants (DOACs) is increasing for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). Despite the good efficacy/safety balance, clinicians will be confronted with patients under treat
Autor:
Rafael Barroso Cabrera, M. D. Caballero, M. J. Pascual, Katy Perez-Equiza, J.J. Lahuerta, José García-Laraña, Jorge Sierra, P. Torres, E. Conde, Javier García-Conde, Aurelio López, J. C. García-Ruiz, Mireia Constans, Joaquín Díaz-Mediavilla, Arturo Iriondo, Anna Sureda, José M. Moraleda, José Rifón, Reyes Arranz, J. Marin, Dolores Carrera, J Petit, A. Torres, Isidro Jarque, Carmen Albo, Juan Besalduch, M.V. Mateos, Enric Carreras, José María Fernández-Rañada, Maria Vidal
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16(4)
Purpose To analyse outcome and prognostic factors for overall survival (OS) and time to treatment failure (TTF) in 357 patients with Hodgkin's lymphoma (HL) undergoing an autologous stem cell transplantation (ASCT) after a first relapse and reported